|Bid||7,724.00 x 0|
|Ask||7,727.00 x 0|
|Day's Range||7,680.00 - 7,747.00|
|52 Week Range||5,871.00 - 10,120.00|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||40.66|
|Earnings Date||Feb 11, 2021|
|Forward Dividend & Yield||2.16 (2.83%)|
|Ex-Dividend Date||Aug 13, 2020|
|1y Target Est||78.83|
A banned Thai opposition politician, who is facing a criminal complaint of defaming the monarchy, defended on Thursday his criticism of the government's coronavirus vaccine strategy that relies on a company owned by King Maha Vajiralongkorn. Thanathorn Juangroongruangkit this week accused the government of Prime Minister Prayuth Chan-ocha of mishandling the vaccine campaign, saying it was too reliant on Siam Bioscience and will be slow to protect the public. The Thai company is owned by the Crown Property Bureau, the organisation that manages tens of billions of dollars in investment under the king's personal control.
Astrazeneca (AZN) closed the most recent trading day at $52.24, moving -0.63% from the previous trading session.
The World Health Organization may approve Moderna's vaccine by the end of next month, according to Reuters.